Crestline Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-200,857
Closed -$3.85M 631
2024
Q4
$3.85M Buy
200,857
+48,315
+32% +$926K 0.13% 177
2024
Q3
$3.47M Buy
+152,542
New +$3.47M 0.18% 136